Status:
COMPLETED
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
University of South Florida
Fordham University
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
The purpose of this study is to examine how well intensive cognitive-behavioral therapy (CBT) delivered over 5 days works in reducing Obsessive-Compulsive Disorder (OCD) symptoms in children and adole...
Detailed Description
Although cognitive-behavioral therapy (CBT) is the most effective intervention for pediatric obsessive-compulsive disorder (OCD), many people do not receive CBT initially due, in part, to the lack of ...
Eligibility Criteria
Inclusion
- All patients must meet the following inclusion criteria to be eligible for study participation:
- Principal diagnosis of OCD on the ADIS-IV-P and CY-BOCS Total Score ≥ 16
- No change in psychotropic medication (if applicable) for at least 8 weeks prior to study entry
- 7 to 17 years old
- Availability of at least one parent to accompany the child to all assessment sessions and be present for videophone assessments
- Have a computer and high-speed internet within their home
- English speaking.
Exclusion
- Patients will be excluded from the study if they meet any of the following criteria:
- History of and/or current psychosis, autism, bipolar disorder, or current suicidality, oppositional defiant disorder, or eating disorder measured by the ADIS-IV-P and all available clinical information
- Principal diagnosis other than OCD
- Current a positive diagnosis in the caregiver of mental retardation, psychosis, or other psychiatric disorders or conditions that would limit their ability to understand CBT (based on clinical interview).
- Participants can be included if they are taking a selective serotonin reuptake inhibitor, SNRI, tricyclic, or antipsychotic provided that no medication changes were made 8 weeks prior to initiation of CBT or during treatment.
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01194076
Start Date
May 1 2010
End Date
May 1 2012
Last Update
May 30 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Florida
Tampa, Florida, United States, 33620
2
Mayo Clinic
Rochester, Minnesota, United States, 55905
3
Fordham University
The Bronx, New York, United States, 10458